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Introduction {#sec1}
============

Epigenetic reprogramming in the mammalian germline is key for restoration of developmental potency and occurs at the preimplantation stage of embryonic development and during development of primordial germ cells (PGCs) ([@bib31]). These events lead to global DNA methylation and H3K9me2 erasure together with the transient transcriptional activation of specific classes of transposable elements (TEs) ([@bib14], [@bib33]). This raises fundamental questions about the regulation of TE defense in the absence of repressive epigenetic marks.

TEs comprise ∼50% of the mammalian genome and can be categorized into two major classes: retrotransposons and DNA transposons ([@bib23]). While most TEs in the genome are inactive due to mutations and/or truncations, around 1%--2% of long interspersed nuclear elements (LINEs) and endogenous retroviruses (ERVs) remain able to retrotranspose ([@bib28]). Notably, the ERV family members intracisternal A particles (IAPs) and early transposons (ETns) are the most active TEs in the murine germline ([@bib28]).

Due to their ability to retrotranspose, TEs are thought to play an important role in genome evolution, but can also cause genetic diseases ([@bib12]). In order to protect the genome from harmful mutations, regulatory mechanisms must be in place to limit their transcription.

TE activity is controlled by multiple epigenetic mechanisms including DNA methylation, repressive histone modifications, and small RNAs ([@bib33]). In somatic tissues, DNA methylation and H3K9me2/3 have been shown to be responsible for TE silencing ([@bib44], [@bib16]). However, in the germline, DNA methylation and H3K9me2 are globally erased, while H3K9me3 is maintained and H3K27me3 is redistributed ([@bib18], [@bib40]). Indeed, deletion of the H3K9me3 methyltransferase *Setdb1* leads to activation of IAPs during PGC development as well as in mouse embryonic stem cells (ESCs) ([@bib19], [@bib28]). Further, global demethylation of naive ESCs results in transcriptional activation of TEs and subsequent resilencing by a redistribution of repressive histone marks ([@bib45]).

A number of studies have demonstrated that small RNAs may also act post-transcriptionally as a second-tier defense against TEs, particularly in the germline. In mouse oocytes, microRNAs (miRNAs) and endogenous short interfering RNAs (endosiRNAs) that control TE expression have been identified ([@bib39], [@bib10], [@bib46]), and in the male germline PIWI-interacting small RNAs (piRNAs) can also control TE expression ([@bib1]). In ESCs, tRNA fragments have been recently described to play a role in ERV translational control ([@bib34]).

In contrast to somatic cells, increased pervasive transcription across TEs was reported in ESCs, suggesting that TEs may regulate transcription of long noncoding RNAs (lncRNAs) ([@bib20]). Intriguingly, however, in yeast it was shown that genome-wide pervasive transcription antisense to transposons leads to an RNAi response as a defense mechanism against TEs ([@bib6]). Sense/antisense transcription permits the production of double-stranded RNA (dsRNA) triggering RNAi ([@bib9]), which has also been identified as a control mechanism of TEs ([@bib32]).

Here we test the hypothesis that genic transcripts antisense to TEs serve as a trap for transcriptional activation of TEs during global demethylation in mammals. Generation of *Dicer* as well as *Ago2* conditional and constitutive knockout ESC lines in the background of a *Dnmt1* conditional knockout (cKO) line allowed us to define an "immediate" endosiRNA-dependent repressive response to TE activation and a subsequent "chronic" response, characterized by targeting of repressive histone modifications.

Results {#sec2}
=======

Acute *Dnmt1* Deletion Leads to TE Demethylation in ESCs {#sec2.1}
--------------------------------------------------------

Our experimental system recapitulates epigenetic reprogramming of early embryos and PGCs *in vitro*. We used Cre-mediated conditional *Dnmt1* deletion in ESCs (*Dnmt1* cKO) ([@bib36]) and sampled DNA and RNA at several defined time points after *Dnmt1* deletion for methylome, long and small transcriptome, and chromatin analyses ([Figure 1](#fig1){ref-type="fig"}A).Figure 1Transcriptional Upregulation of Specific TE Classes upon Acute *Dnmt1* Deletion(A) Left: schematic overview of epigenetic reprogramming during preimplantation and male (blue) and female (red) germline development. Right: schematic of *Dnmt1* cKO as an *in vitro* system for mechanistic study of TE regulation during epigenetic reprogramming.(B) Violin plots showing the distribution of CpG methylation levels measured by WGBS-seq of WT (gray) and conditional *Dnmt1* cKO ESCs induced for days depicted in the figure. The percentage of methylated cytosines was quantified in consecutive 50 CpG windows genome-wide. CGI, CpG island. For significance analysis, Wilcoxon rank-sum test with Bonferroni correction testing with a p value threshold of \<0.05.(C) Heatmap of unbiased hierarchical clustering of all TEs responsive to *Dnmt1* cKO across the time course of KO induction. The relative expression (*Z* score) of TEs upon *Dnmt1* cKO is shown; n = 2.(D) Bar graph showing the percentage of genic antisense transcription upon *Dnmt1* deletion in KO relative to WT samples; n = 2.(E) Chromosome view of TE inserted antisense to gene. Position of TE is denoted (top panel) along with sense strand-specific RNA-seq reads (lower panels; sense transcription shown in blue; antisense transcription shown in red). Each read is depicted. Arrows indicate directionality of reads.(F) Expression of TEs in conditional *Dnmt1* cKO ESC. Shown are normalized RNA-seq read counts overlapping different TE classes in sense (filled bars) or antisense (hatched bars) orientation. The figure shows mean of n = 2.See also [Figures S1](#mmc1){ref-type="supplementary-material"} and [S4](#mmc1){ref-type="supplementary-material"}I and [Data S1](#mmc3){ref-type="supplementary-material"}.

By whole-genome bisulfite sequencing (WGBS-seq), we confirmed that acute deletion of *Dnmt1* led to genome-wide demethylation from an initial 85% CpG methylation to 35% at day 3 after deletion, and 20% at day 6 after deletion with no further demethylation thereafter ([Figures 1](#fig1){ref-type="fig"}B and [S1](#mmc1){ref-type="supplementary-material"}A). The residual methylation can be attributed to the activity of the *de novo* DNA methyltransferases ([@bib25]). Upon *Dnmt1* cKO, loss of methylation was observed in genic and intergenic elements, CGIs, and non-CGI promoters ([Figure 1](#fig1){ref-type="fig"}B). Characteristic methylation profiles over gene bodies were reduced with the same kinetics as the rest of the genome upon *Dnmt1* cKO ([Figure S1](#mmc1){ref-type="supplementary-material"}B). Furthermore, low methylated regions (LMRs) ([@bib37]) and active enhancers became demethylated ([Figure S1](#mmc1){ref-type="supplementary-material"}C). Thus, this *in vitro* model results in replication-dependent global demethylation of the genome, which closely resembles the dynamics of global reprogramming in early embryos and PGCs ([@bib43]).

To analyze TEs in WGBS-seq, RNA-seq, and chromatin immunoprecipitation (ChIP)-seq data, we only considered uniquely mapped reads and filtered out TEs overlapping the (± 2 kb) region surrounding genes. While unique mapping might not capture all information about young TEs (as they lack the increased sequence divergence of older TEs that makes unique mapping more efficient; [@bib26]), this conservative approach allows us to be confident that mapped reads can be definitively ascribed to specific TE subfamilies. Moreover, the filtering of the region (± 2 kb) surrounding genes avoids ambiguity about the origin of TE expression from promoters that are not their own ([Figure S1](#mmc1){ref-type="supplementary-material"}D; [Data S1](#mmc3){ref-type="supplementary-material"}).

Acute *Dnmt1* deletion led to hypomethylation of TEs at the same rate as the rest of the genome ([Figures 1](#fig1){ref-type="fig"}B and [S1](#mmc1){ref-type="supplementary-material"}E), with the exception of IAPs, RLTRs, and MMERVK10C, which preserved higher methylation levels ([Figure S1](#mmc1){ref-type="supplementary-material"}F). Thus, our experimental system also closely recapitulates global demethylation dynamics of TEs *in vivo*, including the fact that IAPs are relatively resistant to global demethylation ([@bib35], [@bib21]).

Increased Sense Transcription of TEs upon Hypomethylation Combines with Pervasive Antisense Transcription {#sec2.2}
---------------------------------------------------------------------------------------------------------

Next, we performed total RNA-seq upon acute *Dnmt1* deletion to examine if demethylation led to transcriptional activation of TEs. Transcriptional activation was limited to specific classes of ERVs ([Figure 1](#fig1){ref-type="fig"}C). We found TEs with increased transcription upon hypomethylation that remained active over the whole time course (MMERVK10C), as well as TEs initially activated but notably subsequently re-silenced (e.g., IAPs and MERVLs).

In addition to TEs, a small number of genes became activated upon loss of DNA methylation ([Figures S1](#mmc1){ref-type="supplementary-material"}G and S1H), including the imprinted genes *Xlr3a*, *Mirg*, and *Rian* ([Table S1](#mmc2){ref-type="supplementary-material"}), consistent with the known roles for methylation in regulation of these genes ([@bib8]) ([Figure S1](#mmc1){ref-type="supplementary-material"}I). DNA hypomethylation did not result in ESC differentiation, as indicated by the unaltered expression of the core pluripotency network ([Figure S1](#mmc1){ref-type="supplementary-material"}J).

Interestingly, when quantifying reads overlapping with genes, we found upon global hypomethylation increased pervasive transcription in the antisense orientation to those genes ([Figure 1](#fig1){ref-type="fig"}D). These pervasive antisense transcripts are in fact produced by transcription of TEs that have integrated in an antisense orientation to the genes ([Figure 1](#fig1){ref-type="fig"}E). Consistent with previous studies, high numbers of TEs were found to be preferentially integrated in antisense orientation to genes ([@bib42]) ([Figure S1](#mmc1){ref-type="supplementary-material"}K).

We next analyzed the total RNA-seq data to determine whether both sense and antisense transcription was detectable at sites of TE integration. Indeed, TE antisense transcription was found in all TE families, with sense transcripts of members of the ERVs being upregulated consistent with their activation in response to demethylation ([Figure 1](#fig1){ref-type="fig"}F). We also included TEs that were not activated by hypomethylation, but instead are regulated in a DICER-dependent manner ([Figure 3](#fig3){ref-type="fig"}E).

Sense/Antisense Transcription of TEs Correlates with AGO2-Bound endosiRNAs {#sec2.3}
--------------------------------------------------------------------------

The production of sense and antisense transcripts across TEs is expected to lead to dsRNAs, which can subsequently induce an RNAi response and silence TEs post-transcriptionally. These results suggest that TE expression may be sensed by pervasive antisense transcription, thus constituting a TE "trap" ([Figure 2](#fig2){ref-type="fig"}A). To test this hypothesis, we performed small RNA-seq at defined time points after *Dnmt1* deletion. The majority of small RNAs were miRNAs ([Figures S2](#mmc1){ref-type="supplementary-material"}A--S2C) and were expressed independently of DNA methylation, with the exception of miRNAs from the imprinted *Dlk* and *Xlr3* loci ([Figures S2](#mmc1){ref-type="supplementary-material"}D and S2E). Small RNA quantitative real-time PCR of mature miRNAs confirmed their methylation-dependent regulation ([Figure S2](#mmc1){ref-type="supplementary-material"}F). The *Dlk* locus serves as an example of the genome-wide response to acute *Dnmt1* deletion with the imprint control region (ICR) becoming demethylated, leading to transcriptional upregulation of the imprinted locus and embedded miRNAs ([Figure S2](#mmc1){ref-type="supplementary-material"}G).Figure 2Generation of TE-Derived Small RNAs following Global Demethylation(A) Schematic displaying the hypothesis of pervasive transcription overlapping TEs acting as a "trap" of transcriptional activation of TEs. This could work through the production of dsRNAs from sense and antisense transcripts that feed into the RNAi pathway, which subsequently silences the TEs.(B) Small RNA-seq reads mapped to different classes of TEs from WT (gray) and conditional *Dnmt1* cKO ESCs. ^∗^p \< 0.05, ^∗∗^p \< 0.005, two-tailed Student's t test. Bars represent mean ± SD, n = 3. All reads of a size between 20 and 24 nt were mapped to TE consensus sequences.(C) Small RNA-seq reads mapped to the consensus sequence of IAPEZ. All reads of a size between 20 and 36 nt were mapped to the IAPEZ consensus sequence.(D) Schematic displaying AGO2 IP of small RNAs.(E) Size distribution of AGO2-bound small RNAs after AGO2 IP of sense (black) and antisense (gray) small RNAs mapping to repeatmasker consensus sequences using the piPipes small RNA-seq pipeline ([@bib15]).(F) Small RNA-seq of AGO2-bound small RNAs mapped to TE classes of WT (gray) and conditional *Dnmt1* cKO ESCs induced for 9 days (light blue). ^∗^p \< 0.05, ^∗∗^p \< 0.005, two-tailed Student's t test. Bars represent mean ± SD, n = 4.See also [Figures S2](#mmc1){ref-type="supplementary-material"} and [S4](#mmc1){ref-type="supplementary-material"}I and [Data S1](#mmc3){ref-type="supplementary-material"}.

Due to the short reads in small RNA-seq, we used TE consensus sequence mapping to analyze global TE-derived small RNAs. This method allows unambiguous alignment to unique TE classes. Notably, we observed a substantial increase of small RNAs mapping to IAP, MERVL, and ETn upon *Dnmt1* deletion ([Figure 2](#fig2){ref-type="fig"}B), which in the case of IAPs mapped across the whole length of the element ([Figure 2](#fig2){ref-type="fig"}C). Small RNAs mapping to L1MdGf and MMERVK10C were detected both in wild-type (WT) and *Dnmt1* cKO ESCs, respectively ([Figure 2](#fig2){ref-type="fig"}B).

The mammalian ARGONAUTE proteins (AGO) are critical components of the RNA-induced silencing complex (RISC). AGO2 can bind miRNAs as well as endosiRNAs and has the ability to "slice" its targets ([@bib7]). We performed AGO2 IP from *Dnmt1* cKO ESCs at day 9 after deletion and analyzed the pull-down by small RNA-seq ([Figure 2](#fig2){ref-type="fig"}D). The AGO2 IP small RNA-seq libraries of both WT and *Dnmt1* cKO ESCs were composed 90% of known miRNAs, while 40% of the remaining small RNAs mapped to TEs ([Figure S2](#mmc1){ref-type="supplementary-material"}H, *Dnmt1* cKO shown). This subset of AGO2-bound small RNAs was 22 nt long and mapped to sense and antisense strands of TEs ([Figure 2](#fig2){ref-type="fig"}E); the small RNAs had 5′ U overhangs ([Figure S2](#mmc1){ref-type="supplementary-material"}I) and formed characteristic 5′-5′ overlaps at nucleotide 20, identifying them as bona fide endosiRNAs ([Figure S2](#mmc1){ref-type="supplementary-material"}J) ([@bib11]). AGO2-bound endosiRNAs mapping to MERVL and RLTR45 were expressed throughout the time course while endosiRNAs mapping to L1, IAP, and ETn or MMERVK10C were significantly enriched upon *Dnmt1* deletion ([Figure 2](#fig2){ref-type="fig"}F), suggesting that functional endosiRNAs against specific TE classes are generated during global demethylation.

We also generated small RNA-seq libraries of male and female PGCs from embryonic day (E)13.5 and E14.5 embryos and found that ∼10% of all 20--24 nt small RNAs mapped to TEs in both male and female E13.5 and E14.5 PGCs, with small RNAs mapping to IAPEZ and L1MdGf particularly enriched in E14.5 PGCs ([Figures S2](#mmc1){ref-type="supplementary-material"}K and S2L). These small RNAs had the defining properties of endosiRNAs ([Figures S2](#mmc1){ref-type="supplementary-material"}M--S2O), suggesting that a similar response to the one we discovered in ESCs exists during global demethylation in the germline *in vivo*.

Key RNAi Components Are Involved in the Repression of Specific TE Classes {#sec2.4}
-------------------------------------------------------------------------

To investigate whether the observed endosiRNAs were involved in restraining TE expression, we knocked down key components of the endosiRNA and miRNA pathways in *Dnmt1* cKO and monitored IAP expression by quantitative real-time PCR. Upon knockdown of *Dicer* or *Ago2*, both essential components of the RNAi pathway, IAP transcription was strongly upregulated, while knockdown of *Dgcr8* (dispensable for endosiRNA function) had no effect on IAP expression ([Figure 3](#fig3){ref-type="fig"}A). This suggests that TEs are controlled by functional endosiRNAs.Figure 3TEs Are Repressed by a DICER Mechanism(A) Knockdown (KD) of RNAi players. Left: schematic of siRNA KD in *Dnmt1* cKO ESCs. The genome gets demethylated (5mC, orange) and IAPs get transcriptionally activated and resilenced (red) if small RNAs are present (gray); however, KD of the RNAi pathway will deplete small RNAs. Lower right: quantitative real-time PCR analysis showing KD efficiencies of *Dicer*, *Ago2*, and *Dgcr8* upon treatment with siRNAs after *Dnmt1* deletion. Upper right: expression of IAPs upon *Dicer*, *Ago2*, *Dgcr8*, or non-targeting siRNA transfection. The data are normalized to non-targeting control. Bars represent mean ± SD, n = 3. ^∗^p \< 0.05, ^∗∗^p \< 0.005, two-tailed Student's t test.(B) Small RNA-seq of *Dicer/Dnmt1* cDKO and *Dnmt1* cKO ESCs. Sense (orange) and antisense (blue) small RNAs are separated by size and were mapped to all TEs. Reads were normalized to non-induced WT (*Dicer*^*fl/fl*^*/Dnmt1*^*fl/fl*^) ESCs.(C) Quantitative real-time PCR analysis of TE classes in ESCs following conditional *Dnmt1* cKO or *Dnmt1*/*Dicer* cDKO by treatment with 4OHT or *Dicer* KO. Bars represent mean of two biological replicates with two technical replicates. Values were normalized to *Atp5b* and *Hspcb*, and major satellites were normalized to U1. ^∗^p \< 0.05, ^∗∗^p \< 0.005, two-tailed Student's t test.(D) Quantitative real-time PCR analysis of IAPEz in the indicated ESC lines. Conditional deletions were induced by treatment with 4OHT for the indicated days. Values were normalized to *Atp5b* and *Hspcb* and are relative to the respective WT sample for each KO line, indicated by dashed line. Error bars represent mean ± SD; n = 3 for *Dnmt1* cKO, *Dicer* KO/*Dnmt1* cKO, and *Ago2* KO/*Dnmt1* cKO; n = 2 for *Dicer/Dnmt1* cDKO and *Ago2/Dnmt1* cDKO. *Ago2* KO/*Dnmt1* cKO time points days 9 and 11 were not collected.(E) Heatmap of unbiased hierarchical clustering of all TE classes responsive to *Dicer* KO. Heatmap depicts relative expression (*Z* score) of TEs upon *Dicer* KO.See also [Figures S3](#mmc1){ref-type="supplementary-material"} and [S4](#mmc1){ref-type="supplementary-material"}I and [Tables S2](#mmc1){ref-type="supplementary-material"} and [S3](#mmc1){ref-type="supplementary-material"}.

To examine the role of the RNAi pathway during global hypomethylation in more detail, we generated conditional *Dicer*/*Dnmt1* cDKO (conditional double-knockout) ESCs ([Figure S3](#mmc1){ref-type="supplementary-material"}A) and carried out a number of quality controls. Loss of *Dicer* activity was confirmed by loss of expression of mmu-miR-93, while *Dicer*-independent small nucleolar RNAs (snoRNAs) were still expressed ([Figure S3](#mmc1){ref-type="supplementary-material"}A). We generated total RNA-seq data from *Dicer/Dnmt1* cDKO ESCs and found increased antisense transcripts in these cells, as seen earlier in the *Dnmt1* cKO ESCs ([Figure S3](#mmc1){ref-type="supplementary-material"}B). Furthermore, small RNA-seq of *Dicer/Dnmt1* cDKO ESCs showed a depletion of all miRNAs ([Figure S3](#mmc1){ref-type="supplementary-material"}C) and a loss of 21--24 nt small RNAs mapping to all TEs as well as specifically to L1MdGf and IAPEz ([Figures 3](#fig3){ref-type="fig"}B and [S3](#mmc1){ref-type="supplementary-material"}D), which proves that the described small RNAs are DICER-dependent products.

Acute conditional deletion of both *Dicer* and *Dnmt1* together resulted in significantly higher levels of transcription of IAPs by day 10 in comparison to those in *Dnmt1* cKO ESCs ([Figure 3](#fig3){ref-type="fig"}C). Importantly, there was no notable resilencing of IAP transcripts in *Dicer/Dnmt1* cDKO. This demonstrates that DICER plays a role in the re-repression of IAPs upon global hypomethylation. LINEs and major satellites (non-TE pericentric repeats), while not upregulated upon *Dnmt1* deletion, were also dramatically upregulated following *Dicer* deletion ([Figure 3](#fig3){ref-type="fig"}C). *Dicer*/*Dnmt1* cDKO ESCs started to show signs of cell death from day 12 after deletion, potentially as a result of TE mobilization, as has been shown in constitutive *Dicer* KO ([@bib3]).

We next asked whether deletion of RNAi components downstream of DICER would lead to a similar response and generated conditional *Ago2*/*Dnmt1* cDKO ESCs ([Figure S3](#mmc1){ref-type="supplementary-material"}E). While we initially expected that *Ago2/Dnmt1* cDKO might show comparable results to the *Dicer/Dnmt1* cDKO, we found that the deletion kinetics of *Ago2* KO were substantially slower than those of *Dicer* KO ([Figures S3](#mmc1){ref-type="supplementary-material"}F and S3G). Surprisingly, however, we found that transcriptional upregulation of TEs in the *Ago2/Dnmt1* cDKO was considerably blunted ([Figure 3](#fig3){ref-type="fig"}D).

To gain deeper insights into the blunted TE expression, we constitutively deleted *Ago2* or *Dicer* using CRISPR/Cas9 genome editing in the background of *Dnmt1* cKO ESCs ([Figures S3](#mmc1){ref-type="supplementary-material"}H--S3J). We first determined the effect of *Dicer* KO on genic and transposon transcription and were able to identify TEs that were solely dependent on DICER for their silencing, such as L1MdGf ([Figures 3](#fig3){ref-type="fig"}E and [S3](#mmc1){ref-type="supplementary-material"}K--S3O).

We next performed a time course of *Dnmt1* deletion in *Ago2* KO/*Dnmt1* cKO and in *Dicer* KO/*Dnmt1* cKO and measured IAP expression by quantitative real-time PCR. Notably, we found substantially attenuated upregulation of IAPs upon *Dnmt1* deletion in both ESC lines, which was confirmed by total RNA-seq ([Figures 3](#fig3){ref-type="fig"}D and [S3](#mmc1){ref-type="supplementary-material"}O). These results indicate that, in addition to DNA methylation and RNAi, alternative TE silencing mechanisms can be recruited. While DICER-dependent mechanisms restrict the expression of specific TE classes upon deletion of *Dnmt1*, ablation of the RNAi pathway prior to demethylation triggers the engagement of another silencing mechanism. Since repressive histone marks have been shown to contribute to TE repression in somatic tissues and in ESCs ([@bib19], [@bib28], [@bib45]), we asked whether these might constitute the additional repressive mechanism observed here.

TE Silencing by Repressive Histone Marks {#sec2.5}
----------------------------------------

To study the involvement of chromatin in TE regulation upon global hypomethylation, we carried out ChIP-seq analyses of the repressive histone marks H3K9me2, H3K9me3, and H3K27me3 at 4 and 8 days after deletion of *Dnmt1*, i.e., before and after transcriptional upregulation of the relevant TE classes. Genome-wide distribution of the repressive histone marks---H3K27me3, H3K9me2, and H3K9me3---confirmed earlier studies ([@bib18], [@bib40]) with H3K27me3 enrichment in gene bodies and H3K9me2/3 enrichment in TEs ([Figure S4](#mmc1){ref-type="supplementary-material"}A). Additionally, H3K27me3 was enriched in promoter regions but depleted at transcription start sites (TSSs) ([Figures S4](#mmc1){ref-type="supplementary-material"}B and S4C). Upon *Dnmt1* deletion, neither of these repressive histone marks were redistributed genome-wide ([Figure S4](#mmc1){ref-type="supplementary-material"}D).

However, DICER-independent MERVLs showed increased H3K27me3 deposition upon *Dnmt1* deletion, recapitulating what has been reported in naive hypomethylated ESCs ([@bib45]) ([Figure 4](#fig4){ref-type="fig"}A). We found H3K9me3 enrichment across IAPs independent of DNA methylation levels, confirming previous results ([Figures S4](#mmc1){ref-type="supplementary-material"}E and S4F) ([@bib45], [@bib36]). Importantly, H3K27me3 and H3K9me2 deposition was found on IAPs 9 days after *Dnmt1* deletion, explaining why early, but not late, depletion of *Dicer* or *Ago2* results in sustained TE expression. These results show that two repressive pathways are in place to control TE expression in ESCs ([Figure S4](#mmc1){ref-type="supplementary-material"}I), and importantly, that they are staggered in time, with an "immediate" RNAi response and a subsequent "chronic" chromatin response.Figure 4Repressive Histone Modifications Enriched at TEs upon Global Demethylation(A) Heatmap showing relative enrichment (*Z* score) of repressive histone marks (H3K9me3, H3K27me3, and H3K9me2) at TE classes differentially regulated upon both *Dicer* KO ([Figure 3](#fig3){ref-type="fig"}A) and *Dnmt1* cKO ([Figure 1](#fig1){ref-type="fig"}C) and normalized to enrichment in WT ESCs upon acute deletion of *Dnmt1*.(B) H3K27me3, H3K9me3, and H3K9me2 enrichment over TEs dependent on *Dicer* and *Dnmt1*. Heatmap depicts ChIP-seq data of H3K27me3 mapped to TE families at depicted days after *Dnmt1* cKO, *Dicer* KO, and *Dnmt1/Dicer* cDKO in comparison to WT ESCs.(C) Schematic of the two levels of TE control upon global demethylation. Upon deletion of *Dnmt1*, DNA methylation (5mC; orange)-mediated repression is lost, and transposon expression increases (as an example, IAP expression is shown in green). Subsequently, small RNAs (red; "immediate" response) and repressive histone marks (chromatin, blue; "chronic" response) establish a new repressive environment. Also indicated are the time points at which the different experimental manipulations interfere with the system.See also [Figure S4](#mmc1){ref-type="supplementary-material"} and [Data S1](#mmc3){ref-type="supplementary-material"}.

To obtain insights into the attenuated IAP expression in *Dicer* KO/*Dnmt1* cKO, we performed ChIP-seq of the same repressive histone marks. While we did not observe a genome-wide redistribution of H3K27me3, H3K9me2, and H3K9me3 in the *Dicer* KO or the *Dicer* KO/*Dnmt1* cKO ([Figures S4](#mmc1){ref-type="supplementary-material"}G and S4H), we observed a clear redistribution of repressive histone marks over TEs in *Dicer* KO and in particular an enrichment of H3K27me3 and of H3K9me2 at IAPs. This was even further increased upon *Dnmt1* deletion ([Figure 4](#fig4){ref-type="fig"}B). Hence, acute deletion of *Dicer* during global demethylation abrogates re-silencing of IAPs while constitutive deletion of *Dicer* instigates a repressive chromatin response in IAPs that suppresses reactivation upon hypomethylation ([Figure 4](#fig4){ref-type="fig"}C).

Discussion {#sec3}
==========

How TEs are controlled during global epigenetic reprogramming in the mammalian germline is a highly relevant question. The present study provides, to our knowledge, the first evidence of AGO2-bound endosiRNAs in ESCs during global DNA hypomethylation, which restrict TE expression as judged by acute depletion of *Dicer* or *Ago2*. As we also detect DICER-dependent endosiRNAs in PGCs, it is likely that the described mechanism also operates *in vivo*. This mechanism constitutes a first line of TE defense during epigenetic reprogramming. A second line of defense is provided by chromatin targeting and retargeting, presumably through the evolution of sequence-specific recognition modules of TEs such as zinc-finger proteins ([@bib33]). Our work also indicates a link between these systems; they are staggered in time and thus potentially connected.

Many TE families are associated with transcribed genes or lncRNAs in ESCs ([@bib20]). This provides the potential for sense/antisense transcription to occur when TEs become demethylated, as observed here ([Figure 1](#fig1){ref-type="fig"}F). In oocytes, pseudogenes provide the antisense strand to TEs to feed into an RNAi pathway ([@bib39]) and TEs have been shown to give rise to dsRNA in preimplantation embryos due to their bidirectional promoters ([@bib38]). Indeed, we found intragenic active TEs preferentially integrated in antisense direction to the gene ([Figure S1](#mmc1){ref-type="supplementary-material"}K). Previous studies had concluded that this could prevent disruption of normal gene expression ([@bib42]). We suggest an additional reason why this direction of insertion is evolutionarily favored: it produces a trapping system ("trap") for transposon activation during epigenetic reprogramming, in order to tame newly invading TEs ([Figure 2](#fig2){ref-type="fig"}A).

Overlapping sense/antisense transcription feeds into an endosiRNA pathway regulated by DICER and AGO2 to silence TEs. The generation of the two constitutive and conditional KO ESCs in the background of the *Dnmt1* cKO allowed us to dissect the dynamics of TE control during global hypomethylation, revealing an "immediate" response that is characterized by endosiRNAs and affected by acute depletion of *Dicer* or *Ago2*. This is followed by a "chronic" response, which is defined by targeting of repressive histone modifications (particularly H3K27me3 and H3K9me2) and occurs subsequent to the endosiRNA response in *Dnmt1* cKO and *Dnmt1/Dicer* cDKO ESCs ([Figure 4](#fig4){ref-type="fig"}C). Intriguingly, non-acute depletion of *Dicer* also instigates deposition of H3K27me3 and H3K9me2 independently of DNA demethylation, suggesting that the two systems are linked. We suggest a mechanism of TE control by which the "immediate" endosiRNA response to global methylation erasure is followed by a "chronic" repressive chromatin response. Interestingly, the "chronic" response is initiated by deletion of *Dnmt1* as well as by abrogation of the "immediate" defense. Therefore, the "immediate" and "chronic" responses are not only staggered in time, but also appear mechanistically linked. Unravelling the molecular underpinnings of this link will be an important topic of future work.

The specific response of IAPs and LINEs to loss of DICER may be explained by the fact that they embody the most active retrotransposition competent TE copies in the mouse germline ([@bib28]) and are primarily guarded by endosiRNAs, with chromatin playing a secondary role in their transcriptional restriction. Other TEs, in contrast, are primarily controlled by chromatin redistribution upon global demethylation. The present study highlights the exquisite variety and interplay of epigenetic modifications by which the transcription of different TE families is regulated. Future work in this area, particularly with high-coverage long-read sequencing, will hopefully allow the characterization of transcriptional and epigenetic regulation of individual TE copies in the genome.

We identified DICER as an important factor in small RNA-dependent silencing of TEs. Nonetheless, DICER-independent AGO2-bound small RNAs may also play a role in TE silencing ([@bib2], [@bib29]). DICER-independent small RNAs might also explain the repression of ETns, to which increasing amounts of AGO2-bound small RNAs mapped, but which were not responsive to *Dicer* KO.

TEs benefit from transcriptional activation in the germline, but not in somatic cells ([@bib13]). Hence, one might speculate that they may regulate aspects of epigenetic reprogramming in germ cells to their benefit. In this respect, TEs may not be the sole benefactors of their own mobilization, but it also impacts the creation of novelty in the host genome. Nevertheless, unrestrained activation and transposition would presumably be detrimental to the host genome, and hence a sophisticated balance of regulatory mechanisms for TEs has evolved in the germline, including the chromatin retargeting and the endosiRNA pathway we report here.

STAR★Methods {#sec4}
============

Key Resources Table {#sec4.1}
-------------------

REAGENT or RESOURCESOURCEIDENTIFIER**Antibodies**anti-CD4 microbeadMiltenyl BiotecCat \#: 130-045-101Alexa Fluor 647, goat anti-mouse IgG antibodyThermo Fisher ScientificCat\# A-21236; RRID: [AB_141725](nif-antibody:AB_141725){#intref0010}Alexa Fluor 568 donkey anti - rabbit IgG antibodyThermo Fisher ScientificCat\# A10042; RRID: [AB_2534017](nif-antibody:AB_2534017){#intref0015}Rabbit Anti-Nanog Polyclonal Antibody, UnconjugatedAbcamCat\# ab80892; RRID: [AB_2150114](nif-antibody:AB_2150114){#intref0020}AGO2 antibodyDr. O'Carrolls labN/AHistone H3K9me3 antibodyActive MotifCat \#: 61013; RRID: [AB_2687870](nif-antibody:AB_2687870){#intref0025}H3K27me3-mouse antibodyActive MotifCat \#: 39155; RRID: [AB_2561020](nif-antibody:AB_2561020){#intref0030}Histone H3K9me2 antibodyAbcamCat \#: ab1220; RRID: [AB_449854](nif-antibody:AB_449854){#intref0035}**Bacterial and Virus Strains**E.coli: One Shot TOP10 chemically competent cellsThermo Fisher ScientificCat \#: K450001**Chemicals, Peptides, and Recombinant Proteins**TamoxifenSigma-AldrichCat \#: T5648-1Gmouse LIFStem Cell Institute, CambridgeN/ANa/DeoxycholateSigma-AldrichCat \#: D6750-10GN-lauroylsarcosineSigma-AldrichCat \#: 61739-5GVanadyl ribonucleoside complexNew England BiolabsCat \#: S1402SLipofectamine 2000Thermo Fisher ScientificCat \#: 11668027Protein G-coupled DynabeadsThermo Fisher ScientificCat \#: 10003DHiFi Uracil+ ReadyMixKAPABiosystemsCat \#: KK2801T4 RNA Ligase 2, truncatedNew England BiolabsCat \#: M0242STri-ReagentSigma-AldrichCat \#: T9424-200MLPhenol/chloroform/isoamylalcohol (25:24:1)Life TechnologiesCat \#: 15593031Triton X-100Sigma-AldrichCat \#: RES9690TDimethylsulfoxide (DMSO)Thermo Fisher ScientificCat \#: TS-20684AmpicillinSigma-AldrichCat \#: A9518-5GPenicillin/StreptomycinThermo Fisher ScientificCat \#: 15140122L-glutamineThermo Fisher ScientificCat \#: 25030081Non-essential amino acidsThermo Fisher ScientificCat \#: 111400502-Mercaptoethanol (50mM)Life technologiesCat \#: 31350-010RNase AThermo Fisher ScientificCat \#: EN0531cOmplete Protease Inhibitor CocktailSigma-AldrichCat \#: 00000001169 7498001Proteinase KThermo Fisher ScientificCat \#: EO0491Paraformaldehyde 16% SolutionAgar ScientificCat \#: AGR1026GelatineSigma-AldrichCat \#: G9391DTTSigma-AldrichCat \#: D0632-1GFetal Bovine Serum (FBS)Stem Cell Institute, CambridgeN/ADMEM (High Glucose) w/L-Glutamine andamp; Na PyrLife TechnologiesCat \#: 41966-052NEBuffer 2New England BiolabsCat \#: B7002STrypsin EDTA (1x) 100mlLife technologiesCat \#: 25300-054HyperLadder 1kb, 100bpBiolineCat \#: BIO-33053, BIO-33029SYBR SafeInvitrogenCat \#: S33102SYBR GoldLife TechnologiesCat \#: S11494PvuINew England BiolabsCat \#: R0150SEcoRI HFNew England BiolabsCat \#: R3101LT4 Polynucleotide KinaseNew England BiolabsCat \#: M0201LT4 LigaseNew England BiolabsCat \#: M0202TAmpure XP beadsBeckman CoulterCat \#: A63880T5 ExonucleaseNew England BiolabsCat \#: M0363SExonuclease INew England BiolabsCat \#: M0293SKlenow exo-New England BiolabsCat \#: M0212LGlycoblueAmbionCat \#: AM9516OptimemGIBCOCat \#: 31985062DAPIThermo Fisher ScientificCat \#: 62248MyTaq RedmixBiolineCat \#: BIO-25043Orange G dyeSigma-AldrichCat \#: 861286-25G**Critical Commercial Assays**TruSeq Small RNA Library Prep Kit -Set A (24 rxns) (Set A-c: indexes 1-36)IlluminaCat \#:RS-200-0012, RS-200-0024, RS-200-0036NEBNext DNA Library Prep Master Mix Set for IlluminaNew England BiolabsCat \#: E6040SImprint DNA Modification KitSigma-AldrichCat \#: MOD50-1KTTruSeq RNA library preparation kit v2IlluminaCat \#: RS-122-2001MicroPlex Library Preparation kitDiagenodeCat \#: C05010012SmallRNA qRTPCR miRNA kit: mmu_miR93TaqmanCat \#: TM001090SmallRNA qRTPCR miRNA kit: mmu_miR7081_matTaqmanCat \#: TM467052_matSmallRNA qRTPCR miRNA kit: snoRNA202TaqmanCat \#: 001232Dharmacon siGENOME SMARTpool, mouse DicerDharmaconCat \#: MU-040892-01-0005Dharmacon siGENOME SMARTpool, mouse Dgcr8DharmaconCat \#: MU-051365-00-0002Dharmacon siGENOME SMARTpool, mouse Ago2DharmaconCat \#: MU-058989-01-0005Dharmacon siGENOME SMARTpool, mouse DicerDharmaconCat \#: D-001210-02-05Miniprep kitQIAGENCat \#: 27106Gel extraction kitGeneJETCat \#: K0691PCR Purification kitGeneJETCat \#: K0701Qiaamp DNA micro kitQIAGENCat \#: 56304TURBO DNA-free kitLife TechnologiesCat \#: AM1907Quant-iT PicoGreen dsDNA Assay kitLife TechnologiesCat \#: P11496Platinum SYBR Green qPCR SuperMix-UDG w/ROXLife TechnologiesCat \#: 11744100QuickExtractEpicenterCat \#: QE09050Kapa Library Quantification kitKapa BiosystemsCat \#: KK4847High Sensitivity DNA kitAgilentCat \#: 5067-4626High Sensitivity total RNA kitAgilentCat \#: 5067-1513**Deposited Data**Raw and analyzed dataThis studyGEO: [GSE89698](ncbi-geo:GSE89698){#intref0040}Mouse reference genome NCBI build 37, NCBIM37Mouse Genome Sequencing Consortium<http://may2012.archive.ensembl.org/Mus_musculus/Info/Index>Mouse repeatsrepeatmasker v4.0.3, library version 20130422<http://www.repeatmasker.org/>Mouse ESCs enhancer annotation track[@bib4], [@bib5]N/ACpG island promoters[@bib17]N/APromoters: regions −1kb to the transcription start siteEnsemble, NCBIM37 version 67N/A**Experimental Models: Cell Lines***Dnmt1* cKO: Passage 12 Dnmt1^loxP/loxP^ (C57BL/6) ESCs[@bib36]N/A*Dicer/Dnmt1* cDKO: Passage 21 Dicer ^loxP/loxP^/Dnmt1 ^loxP/loxP^ ESCsThis studySee STAR Methods section [CRISPR cKO and KO](#sec4.4.6){ref-type="sec"}*Ago2/Dnmt1* cDKO: Passage 21 Ago2 ^loxP/loxP^ /Dnmt1 ^loxP/loxP^ ES cellsThis studySee STAR Methods section [CRISPR cKO and KO](#sec4.4.6){ref-type="sec"}*Dicer* KO: Passage 17 *Dicer* KO/*Dnmt1*^loxP/loxP^ ES cellsThis studySee STAR Methods section [CRISPR cKO and KO](#sec4.4.6){ref-type="sec"}*Ago2* KO: Passage 17 *Ago2* KO/*Dnmt1*^loxP/loxP^ ES cellsThis studySee STAR Methods section [CRISPR cKO and KO](#sec4.4.6){ref-type="sec"}**Experimental Models: Organisms/Strains**Mouse: C57BL/6J female mice carrying the Oct4-GFP transgene in the developing gonad: B6.Cg-Tg(GOF18/EGFP)11Ymat/Rbrc[@bib47]RRID: IMSR_RBRC00868**Oligonucleotides**Primers for CRISPR clone generation, see [Table S3](#mmc1){ref-type="supplementary-material"}This paperN/APrimers for RTqPCR clone generation, see [Table S2](#mmc1){ref-type="supplementary-material"}This paperN/A**Recombinant DNA**Cas9 plasmid: pSpCas9(BB)-2A-GFP[@bib30]Addgene Plasmid \#48138pSpCas9(BB)-2A-hCD4This studyN/A**Software and Algorithms**Bowtie2[@bib24]<http://bowtie-bio.sourceforge.net/bowtie2/index.shtml>Bismark[@bib22]<https://www.bioinformatics.babraham.ac.uk/projects/bismark/>, version 0.14.4TopHat[@bib41]<http://ccb.jhu.edu/software/tophat/index.shtml>piPipes[@bib15]<https://github.com/bowhan/piPipes/wiki>Trim GaloreN/A<http://www.bioinformatics.babraham.ac.uk/projects/trim_galore/>, Version 0.4.1SeqMonk softwareN/A<http://www.bioinformatics.babraham.ac.uk/projects/seqmonk/>DESeq2[@bib27]<https://bioconductor.org/packages/release/bioc/html/DESeq2.html>, version 3.5Transposon analysisthis studySTAR Methods section [Transposon analysis](#sec4.5.5){ref-type="sec"}RData analysis<https://www.r-project.org/>, version 3.2.5Adobe IllustratorFigures<http://www.adobe.com/de/products/illustrator.html>, version CC 2015.3

Contact for Reagent and Resource Sharing {#sec4.2}
----------------------------------------

Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Rebecca Berrens (<rebecca.berrens@gmail.com>). The AGO2 antibody was obtained from EMBL, after establishing an MTA with the laboratory of Prof. Donal O'Carroll at University of Edinburgh.

Experimental Model and Subject Details {#sec4.3}
--------------------------------------

### Cell lines {#sec4.3.1}

Mouse embryonic stem cell (ESC) lines were used in this study. *Dnmt1*^loxP/loxP^ ESCs (strain C57BL/6) were obtained from Haruhiko Koseki, RIKEN Center for Integrative Medical Sciences, Yokohama City, Japan ([@bib36]). *Dicer/Dnmt1* cDKO, *Ago2/Dnmt1* cDKO, *Dicer* KO and *Ago2* KO ESC lines were generated using *Dnmt1*^loxP/loxP^ ESCs using the CRISPR/Cas9 targeting and screening primers mentioned in [Table S3](#mmc1){ref-type="supplementary-material"}.

### Mice {#sec4.3.2}

All *in vivo* PGC samples were collected from timed matings of C57Bl/6J male with C57BL/6J female mice carrying the Oct4-GFP transgene expressed in the developing gonad ([@bib47]). Primordial germ cells from male and female embryos at E13.5 and E14.5 were collected. All procedures were covered by a project license (to WR) under the Animal (Scientific Procedures) Act 1986, and are locally regulated by the Babraham Institute Animal Welfare, Experimentation, and Ethics Committee.

Method Details {#sec4.4}
--------------

### DNA/RNA Extraction {#sec4.4.1}

Genomic DNA was prepared using QIAmp DNA Micro Kit (QIAGEN). RNA was extracted using TriReagent (Sigma) and Phase Lock tubes (5Prime) following manufacturers' instructions and subjected to DNase treatment using the DNA-free kit (Ambion DNA-free DNA Cat \#1311027) according to the manufacturers' instructions.

### Small RNA Quantitative Real-Time PCR {#sec4.4.2}

For small RNA qPCR Taqman miRNA kits were used according to the manufacturer's' instructions for mmu_miR93 (Taqman, Cat. No. TM001090), mmu_miR7081_mat (Taqman, Cat. No. TM467052_mat) and snoRNA202 (Taqman, Cat. No. 001232) was used as a positive control. Quantitative real-time PCR primers are listed in [Table S2](#mmc1){ref-type="supplementary-material"}.

### AGO2 IP {#sec4.4.3}

ESCs were cultured on 15 cm dishes and harvested in 1 x PBS. Pellets were frozen at −80°C until further processing. ESC were resuspended in 300 μl Lysis buffer (50 mM Tris, pH8, 150 mM NaCl, 5 mM MgCl~2~, 15% Glycerol, 1 mM DTT, 0.5% Sodium deoxycholate, 0.5% Triton X-100, Protease inhibitor cocktail (Roche), 50μg/ml yeast tRNA, 2mM Vanadyl ribonucleoside complex) and cells were pelleted at 10,000 rpm, 10 min, 4°C. The supernatant was used as whole ESC extract. 25 μL beads (protein G Sepharose) were washed 3 times with 1 mL of Wash Buffer (10 mM Tris pH 8, 150 mM NaCl, 1 mM MgCl~2~, 0,01% NP-40). 50 μl of purified AGO2 antibody (O'Carroll lab) was added, filled up to 1mL with Wash Buffer and incubated O/N at 4°C in a rotating wheel. On the next day, the beads were washed 3 times with Wash Buffer and the negative control (beads with extract but without serum) was prepared. The ESC extract was pre-spun to remove precipitated proteins and 200μL extract was added to the beads and filled up to 600μL with Lysis buffer. The mix was incubated for 2-4h at 4°C in a rotating wheel and subsequently washed 5 times with wash buffer and the IP was eluted with 300μL Proteinase K buffer (10 mM Tris pH 7,5, 0,5% SDS, 5 mM EDTA, 1 μL Proteinase K/reaction) after 30 min for 50°C incubation on the thermomixer, at 850 rpm. RNA was isolated by phenol extraction and eluted in 8 μl H~2~O.

### RNAi knockdown of Ago2, Dicer1, Dgcr8 in Dnmt1fl/fl ES cells {#sec4.4.4}

RNA interference experiments were performed according to manufacturers' instructions with modifications. Transfections of Dharmacon siGENOME SMARTpool siRNA against mouse *Dicer* (Dharmacon, Cat. No. MU-040892-01-0005), *Dgcr8* (Dharmacon, Cat. No. MU-051365-00-0002) or *Ago2* (Dharmacon, Cat. No. MU-058989-01-0005) and siGENOME non-targeting siRNA\#2 (Dharmacon, Cat. No. D-001210-02-05) were performed with Lipofectamine 2000 according to the manufacturers' instructions. The transfection was done in two rounds. The cells were plated at a density of 1 × 10ˆ5 ES cells per well of gelatinized 12-well plate. One day later the first transfection was done the following for each well of a 12 well plate: 50uM siRNA were added to 100 μl DMEM. 6 μl of Lipofectamin2000 were mixed with 100 μl DMEM. The mix was incubated for 5 min at room temperature. Afterward the two solutions were mixed and incubated at room temperature for 15 min. 200 μl of the siRNA and Lipofectamin2000 mix were added to each well of a 12 well plate. On the third day the medium was changed. On the fourth day the second transfection was done the following: 125uM siRNA were added to 250 μl DMEM. 7.5 μl of Lipofectamin2000 were added to 250 μl DMEM and incubated at room temperature for 5 min. The solutions were then mixed and again incubated for 15 min at room temperature. The cells were washed with PBS, trypsinized, inactivated and resuspended in ESC medium and plated on a gelatinized 6-well plate I a total volume of 1.8 mL each well. 500μl of siRNA and Lipofectamin2000 were added to each well. The ESCs were incubated at 37C for 6 hours and then the medium was changed.

Cells were harvested 48 h after the 2^nd^ transfection and RNA was extracted and analyzed.

### Quantitative Real-Time PCR {#sec4.4.5}

100 ng −1 μg of DNase treated RNA was reverse transcribed (Thermo RevertAid \#K1622) using random hexamer primers. Endogenous controls (*Atp5b*, *Hspcb*, *U1*) were used to normalize expression. Primers are listed in [Table S2](#mmc1){ref-type="supplementary-material"}.

### CRISPR cKO and KO {#sec4.4.6}

guideRNAs (gRNAs) were constructed following <https://chopchop.rc.fas.harvard.edu/> and <http://crispr.mit.edu/> and cloned following the protocol by [@bib30] into pSpCas9(BB)-2A-GFP (Addgene plasmid ID: 48138) or pSpCas9(BB)-2A-hCD4, constructed by replacing the GFP in the pSpCas9(BB)-2A-GFP with human CD4. Cells were cultured on feeder plates and transfected with 1 μg gRNA and 100 ng donor DNA, where appropriate, using Lipofectamine 2000 transfection reagent. Cells were sorted for GFP in single cell colonies into 96 well plates using flow cytometry or CD4 expression plating on 10cm dishes as single cell colonies. Colonies were screened by PCR using MyTaq (Bioline, BIO-25044) and Sanger sequencing. See [Figure S3](#mmc1){ref-type="supplementary-material"} for knock out strategy and [Table S3](#mmc1){ref-type="supplementary-material"} for gRNAs, screening primers and donor DNA sequence.

### Fluorescence-activated cell sorting (FACS) {#sec4.4.7}

Cells were trypsinized and resuspended in PBS + 1% FBS and analyzed on a LSR Fortessa Cell Analyzer (BD). Cells were gated for singlets and living cells were identified using the level of DAPI incorporation and the level of GFP signal was recorded for each cell.

### CD4 pull down {#sec4.4.8}

Cells were trypsinized and resuspended in 70 μl 1 x PBS and stained with human CD4 Microbead antibody (Miltenyl Biotec, Cat. No. 130-045-101) according to manufacturers' instructions. The CD4 positive cells were enriched using MACS columns. Negative cells were collected from flow through. The cells were eluted in 500 μl 1 x PBS.

### *In vivo* PGC collection {#sec4.4.9}

All embryonic samples for library preparation were collected from timed mattings of C57BL/6J female mice PGCs that express the Oct4-GFP transgene in the developing gonad ([@bib47]). E13.5 and E14.5 PGCs, male and female samples were collected separately and after collagenase digestion PGC samples were sorted for GFP positive cells using a FACSAria (BD) cell sorter with \> 98% purity.

### Cell lines and culture conditions {#sec4.4.10}

Mouse ESCs were cultured with or without feeders on gelatinized plates (0.1% gelatin) in serum-containing media (DMEM 4,500 mg/l glucose, 4 mM L-glutamine, 15% fetal bovine serum, 1 U/ml penicillin, 1 μg/ml streptomycin, 0.1 mM nonessential amino acids, 50 μM β-mercaptoethanol) supplemented with mouse LIF at 37°C and 5% CO~2~. Conditional deletion was induced by Cre mediated recombination, as described before ([@bib36]). Cre expression was induced in response to tamoxifen (4OHT, 800 nM).

### WGBS-seq libraries {#sec4.4.11}

For preparation of WGBS-seq libraries, genomic DNA was sonicated using a Covaris Sonicator, followed by end-repair, A-tailing and methylated adaptor (Illumina) ligation using NEBNext reagents (E6040S, NEB). Afterward the libraries were bisulfite treated using Imprint DNA modification kit (MOD50-1KT, Sigma), followed by library amplification with indexed primers using KAPA HiFi Uracil HotStart DNA Polymerase (KAPA HiFi Uracil+, KK2801/2). Subsequently, the amplified libraries were purified and assessed for quality and quantity using High-Sensitivity DNA chips on an Agilent Bioanalyzer. High-throughput sequencing of all libraries was carried out with a 75 bp or 50 bp paired-end (PE) sequencing on Illumina HiSeq 2500 instruments using TruSeq reagents (Illumina, San Diego, CA, USA), according to manufacturers' instructions.

### ChIP-seq libraries {#sec4.4.12}

ESCs were grown on 15 cm dishes coated with 0.1% gelatine until they were 80% confluent. Subsequently cells were cross-linked with 1% methanol-free formaldehyde in fresh medium for 10 minutes. To quench the cross-linking, 0.2 M final concentration of glycine was added. ESCs were washed twice with ice cold 1 x PBS (137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 2 mM KH2PO4 dissolved in 800 mL distilled H2O, pH was adjusted to 7.4 with HCl) and harvested using a cell scraper. Cells were then pelleted by centrifugation at 8,000 x g at 4 ◦C for 3 min. Pellets were resuspended in LB1 buffer (50 mM HEPES' KOH, pH 7.5; 140 mM NaCl; 1 mM EDTA; 10% glycerol; 0.5% NP-40; 0.25% Triton X-100, protease inhibitors) for 10 minutes at 4°C, pelleted and resuspended in LB2 buffer (10 mM Tris/HCl, pH 8.0; 200 mM NaCl; 1 mM EDTA; 0.5 mM EGTA, protease inhibitors) for 10 minutes at 4 ◦C. Cells were pelleted and resuspended in LB3 buffer (10 mM Tris-HCl, pH 8; 100 mM NaCl; 1 mM EDTA; 0.5 mM EGTA; 0.1% Na/Deoxycholate; 0.5% N-Lauroylsarcosine, protease inhibitors). Next the cells were sonicated using Misonix Sonicator 3000. Triton X-100 was added to a final concentration of 1% and the lysate was centrifuged at 20,000 x g for 10 min to pellet the debris. The bead-antibody complexes were prepared before adding the sonicated DNA. Protein G-coupled Dynabeads (Thermo Fisher Scientific, Cat. No. 10003D) and the primary antibodies in PBS with 5 mg/ml BSA were incubated ON. Subsequently, the bead-antibody complexes were added to the sonicated chromatin and both were incubated at 4 ◦C ON. On the following day, beads were washed extensively with RIPA buffer (50 mM HEPES pH 7.6, 1 mM EDTA, 0.7% Na deoxycholate, 1% NP-40, 0.5M LiCl), once with 1x TE bu er (1 M Tris-HCl (pH approximately 8.0), 0.1 M EDTA) and eluted in 200 μL of buffer containing 1% SDS and 0.1 M NaHCO3. They were then incubated at 65°C ON for reverse cross-linking. RNase A treatment at 37°C was carried out for 1 h, then Proteinase K treatment at 55°C for 2 h. The DNA was then extracted with phenol/chloroform, followed by ethanol precipitation. ChIP-seq library preparation was performed using MicroPlex Library Preparation kit (Diagenode) following manufacturer's instructions. Libraries were quantified using the High Sensitivity DNA Bioanalyzer kit and Kapa library quantification. High-throughput sequencing of all libraries was carried out with a 100 bp PE sequencing on Illumina HiSeq 2500 instruments.

### Small RNA-seq libraries {#sec4.4.13}

Small RNA-seq libraries were produced according to the Illumina protocol (RS-200-0012), with the following changes: 10 ng or 1 μg RNA (RIN of 8-10) were used as input material. The instructions were followed until the cDNA purification. In order to purify the cDNA, the samples were run on 10% Novex PAGE gel. The entire area between the 145 and 160 bp markers was excised, gel purified by addition of 0.3 M NaCl and the DNA was eluted from the gel by rotation over night at 4°C. The DNA was precipitated in EtOH overnight and the library was quantified using the HighSensitivity Bioanalyzer kit. The small RNA-seq libraries were additionally quantified by Kapa Library Quantification. The libraries were pooled according to their molecular weight. High-throughput sequencing of all libraries was carried out with a 50 bp SE on Miseq or SE and PE on Illumina HiSeq 2500 instruments.

### Total RNA-seq libraries {#sec4.4.14}

Stranded Total RNaseq libraries were prepared according to manufacturers' protocols using the Illumina stranded Total RNaseq library preparation after Ribo-zero depletion. High-throughput sequencing of all libraries was carried out with a 100 bp PE on Illumina HiSeq 2500 instruments.

Quantification and Statistical Analysis {#sec4.5}
---------------------------------------

### WGBS-seq mapping and analysis {#sec4.5.1}

Raw sequence reads from WBGS libraries were trimmed to remove poor quality reads and adaptor contamination, using Trim Galore (v0.4.1, <http://www.bioinformatics.babraham.ac.uk/projects/trim_galore/>) with default parameters. The remaining sequences were mapped using Bismark (v0.14.4) ([@bib22]) with default parameters to the mouse reference genome Ensembl v67 NCBIM37 in paired-end mode. Reads were then deduplicated and CpG methylation calls were extracted from the deduplicated mapping output using the Bismark methylation extractor (v0.14.4) in paired end mode. CpG methylation calls were analyzed using R and SeqMonk software (<http://www.bioinformatics.babraham.ac.uk/projects/seqmonk/>). The custom R scripts can be found in Data S1. Global CpG methylation levels of pooled replicates were calculated in windows of 50 CpGs with a coverage of at least 3, illustrated using bean plots. Methylation over a given genomic feature was calculated by averaging the individual methylation levels of CpGs covered by at least 3 reads and only features with at least 50 CpGs were used. Promoters were defined as the region −1 kb to the transcription start site as annotated in Ensembl NCBIM37 v67. For analysis of specific genome features these were defined as follows: Gene bodies (probes overlapping genes), CGI promoters (promoters containing a CGI) ([@bib17]), non-CGI promoters (all other promoters).

### RNA-seq mapping and analysis {#sec4.5.2}

RNA-seq sequences were trimmed using Trim Galore using default settings. Trimmed sequencing reads were aligned to mouse genome assembly NCBIM37 using TopHat ([@bib41]) and reads with MAPQ scores \< 20 were discarded. Mapped RNA-seq data were quantitated using the RNA-seq quantitation pipeline in SeqMonk software to generate log2 RPM (reads per million reads of library) expression values. Genes were considered to be differentially expressed if they were significantly different (p \< 0.05 after Benjamini and Hochberg multiple testing correction) when analyzed with both DESeq2 and Intensity difference (SeqMonk) statistical tests.

Global pervasive transcription, was calculated as following: Genes with significant antisense expression were identified by initially counting both sense and antisense reads over all genes in the genome. A global expected antisense level was defined by the total proportion of antisense reads across all genes. Individual genes were considered to show significant antisense expression if they had a binomial p value \< 0.05 following multiple testing correction (FDR) using the global antisense proportion as the expected success rate, the total reads for that gene as the trials and the total antisense reads for that gene as successes. Additionally, the raw antisense transcription counts for all samples was calculated and significant differential antisense expression was calculated using DESeq2 with an FDR \< 0.05. The overlap of the two quantifications was used to define pervasive transcription, and the difference in antisense transcription between WT and KO samples at each time point was plotted using R.

### ChIP-seq mapping and analysis {#sec4.5.3}

ChIP-seq sequencing data was trimmed to remove poor quality reads, adaptor and barcodes sequences using Trim Galore. Trimmed data were mapped using Bowtie2 ([@bib24]) against the mouse reference genome Ensembl v67 NCBIM37 and reads with a MAPQ value \< 20 were discarded. Mapped ChIP-seq data were quantitated creating 1kb tiles of the whole genome and calculating the log2 observed/expected value comparing the observed read count with the expected count had all reads been uniformly distributed over the genome.

### Small RNA-seq mapping and analysis {#sec4.5.4}

For small RNA-seq data analysis trimmed sequencing reads were filtered to 20-24nt length and mapped to the mouse NCBIM37 genome assembly using Bowtie2. Raw overlap counts for each small RNA molecule were quantitated using SeqMonk. Graphing and statistics was performed using Excel or R. For consensus sequence mapping the piPipes small RNA pipeline was used (<https://github.com/bowhan/piPipes>) ([@bib15]). IAPEZ consensus sequences were used from repeatmasker libraries (repeatmasker v4.0.3, library version 20130422). Additionally, the small RNA-seq data processing was performed using the freely available piRNA pipeline piPipes. For repeat mapping, trimmed data were mapped using Bowtie2 against repeats as defined in the analysis by using the mouse repeatmasker annotation. The plots shown were generated as described below: The distribution of small RNAs was computed by mapping all small RNA-seq reads to the individual genomic features. The length distribution was calculated taking all uniquely mapped small RNAs into account, excluding small RNA-seq mapping to ribosomal RNAs (rRNAs). For all subsequent analysis, small RNA reads were pre-filtered as follows: reads mapping to rRNAs and miRNAs were excluded, then reads aligning to the repeat masked mm9 genome (all annotated repeats were masked/replaced by Ns) were removed, too. The remaining small RNAs reads were mapped to the mouse repeatmasker annotation. The 5′ end nucleotide composition was computed from the uniquely mapped small RNAs. Similarly, analysis of the position of 5′ to 5′ overlap was performed on the mapped small RNAs reads and the length distribution and strand orientation of small RNAs shown was generated using uniquely mapped small RNA reads.

### Transposon analysis {#sec4.5.5}

Repeat locations for a pre-defined set of repeat classes of interest were extracted from the pre-masked repeatmasker 4.0.3-20130422 library in the mm9 genome. Repeat instances within 2 kb of an annotated gene in the Ensembl v67 NCBIM37 gene set were removed to avoid mixing signals from genic expression with specific expression of repetitive sequences. RNA-seq data were processed and mapped as described above ([RNA-seq mapping and analysis](#sec4.5.2){ref-type="sec"}). We set a standard outlier filtering approach with a cutoff of counts \> 3. Overlaps were quantitated between the mapped RNA-seq reads and the repeat instances. This allowed an unbiased identification of TEs depending on *Dnmt1 KO* as well as *Dicer KO*, which we followed throughout this manuscript. Summed counts for all instances of each class of repeat were calculated and these were corrected for both the total length of all TEs and the size of the individual libraries to generate log2 RPM expression values. The matrix of expression values and samples were plotted using the R pheatmap library allowing the repeat classes to cluster using default parameters. WGBS-seq libraries were processed and mapped as described above ([WGBS-seq mapping and analysis](#sec4.5.1){ref-type="sec"}). Methylation levels at the repeat instances were quantitated by summing up all methylation calls and non-methylation calls for all instances of each class of repeat and calculating the percentage of methylated Cs over all Cs. Only TEs with at least 1000 observations in all samples were used for the analysis and calculation of percentage methylation. For major satellite methylation analysis Bismark ([@bib22]) was used to map all reads against the mouse major satellite consensus sequence (GSAT from repeatmasker) and the methylation calls from these results were analyzed directly. The custom R scripts can be found in [Data S1](#mmc3){ref-type="supplementary-material"}.

### Statistics {#sec4.5.6}

Statistical values including the exact number of replicates (n), the definition of standard deviation and statistical significance are reported in the Figure Legends.

#### WGBS-seq {#sec4.5.6.1}

For statistical analysis WGBS-seq of [Figures 1](#fig1){ref-type="fig"}B and [S1](#mmc1){ref-type="supplementary-material"} of WT versus *Dnmt1* KO data we used the Wilcoxon rank sum test with Bonferroni correction testing with a p value threshold of \< 0.05. The code of the analysis of the retained methylation over TEs can be found in [Data S1](#mmc3){ref-type="supplementary-material"}.

#### Total RNA-seq {#sec4.5.6.2}

To call differentially expressed mRNAs, we applied the SeqMonk intensity difference filter with Benjamini and Hochberg correction for multiple testing with a p value threshold of \< 0.05 and overlapped them with the genes called differentially expressed by DESeq2 with a p value threshold of \< 0.05 and multiple testing correction.

For TE analysis we only considered significantly differentially expressed TEs p \< 0.05 of Dnmt1 KO over WT samples into account. The code of the analysis can be found in [Data S1](#mmc3){ref-type="supplementary-material"}.

#### small RNA-seq {#sec4.5.6.3}

To call differentially expressed miRNAs we overlapped the differentially expressed miRNAs using DESeq2 with multiple testing correction and SeqMonk intensity difference filter with Benjamini and Hochberg correction with a p value of \< 0.05.

To call differential amount of mapped small RNAs to TEs we used Students t test to compare day 8 to day 0 enrichment of small RNAs with a p value of \< 0.05.

#### ChIP-seq {#sec4.5.6.4}

As we only have data from one measurement we could not call significant differences of histone modification enrichment but show TEs which have at least 2 times higher enrichment in Dnmt1 KO versus WT samples. The code of the analysis can be found in [Data S1](#mmc3){ref-type="supplementary-material"}.

#### Quantitative Real-Time PCR {#sec4.5.6.5}

Each quantitative real-time PCR was done with 3 technical replicates. Differences between conditions that are statistically significant are denoted by ^∗^p value \< 0.05, ^∗∗^p value \< 0.005 using the standard distributed two tailed t test.

#### siRNA knock-down {#sec4.5.6.6}

Every siRNA knock-down was done in 3 technical replicates. Differences between conditions that are statistically significant are denoted by ^∗^p value \< 0.05, ^∗∗^ p value \< 0.005 using the standard distributed two tailed t test.

Data and Software Availability {#sec4.6}
------------------------------

The accession number for the next-generation-sequencing data reported in this study is GEO: [GSE89698](ncbi-geo:GSE89698){#intref0130}. The software of this study can be found in [Data S1](#mmc3){ref-type="supplementary-material"}.
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